A sleeper hit 2020 PlayStation 4 action RPG is getting a PS5 sequel, and surprisingly soon, its publisher has confirmed.
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that its wholly owned subsidiary, Virax Biolabs (UK) Limited, has entered into an exclusive multi-country ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results